News & PR | alphatau

Investors | Stock Information | SEC Filings | Events & Presentation | News & PR | Corporate Governance

Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

Alpha Tau Medical

Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

JERUSALEM, Nov. 3, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective

Alpha Tau Medical

Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective

JERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

Alpha Tau Medical

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

JERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to...

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid...

First Alpha DaRT Patient Treated in the US as Part of Pilot Multicenter Skin Cancer Trial

First Alpha DaRT Patient Treated in the US as Part of Pilot Multicenter Skin Cancer Trial

Jerusalem, Israel, July 6, 2021 - Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRTTM,...

Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™

Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™

JERUSALEM, June 8, 2021 /PRNewswire/ -- Alpha Tau Medical, the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT,TM...

1

2 3 4